Industry Reports
Each report pulls together a period of deals, announcements, and published data on one question facing clinical research sites and the organizations that select and fund them.
Latest Reports
Where a case study examines a single event, a report looks across many. Each one is written for a specific audience and cites every figure it uses.
Site Selection in 2026: New Tools, an Old Problem, and Little Independent Evidence
At least eight companies announced AI-driven site selection or feasibility tools in 2026. This report reviews what each one claims, what data it uses, and how those claims compare with the published evidence on why sites under-enroll.
The Cost of Feasibility: What Questionnaires and Qualification Visits Take From Sites
Published research puts the cost to sites of feasibility assessments and qualification visits at $170 million in 2024. This report brings together the available data on how much time the process takes, how much of it is repeated, and what sites get back.
Who Is Buying Clinical Research Sites: Deals and Due Diligence, 2025–2026
We identified more than 20 acquisitions, mergers, and investments involving clinical research sites and site networks between January 2025 and November 2026. This report lists them, summarizes what is known about valuation, and sets out what buyers examine before they commit.
How We Write These
Our reports are information first. The analysis has to stand on its own before we say anything about our own products.
The Tools Behind the Analysis
SiteScore™ verifies and benchmarks clinical research site performance. FeasComplete™ helps sites answer feasibility requests faster.